Self-induced Anuria with Diclofenac: An Interesting Case of “Quadruple Whammy” Acute Kidney Injury
International Journal of Medical Toxicology and Forensic Medicine,
Vol. 14 No. 02 (2024),
24 April 2024
https://doi.org/10.32598/ijmtfm.v14i02.43065
Abstract
Background: Non-steroidal anti-inflammatory drugs (NSAIDs) are a group of drugs widely prescribed and used worldwide. Patients taking NSAIDs, including diclofenac, should be aware of its potential nephrotoxic effects. However, the rapid onset of acute kidney injury (AKI) after a single dose of diclofenac is considered a very rare side effect.
Case Presentation: We present a 66-year-old woman with habitual self-induced anuria with the chief complaint of shoulder pain due to falling down. The patient presented with various co-morbid conditions, including hypertension, type 2 diabetes, tricuspid valve repair, and aortic valve replacement. She rapidly developed anuria after receiving a single dose of diclofenac over the previous two days of admission. Creatinine and BUN exhibited a significant rise in laboratory tests. During hospitalization, the consumption of NSAIDs was prohibited and losartan and furosemide were discontinued. Moreover, phenacetin was used to relieve pain instead. Luckily, after two days of hospitalization, urine output returned to normal levels. Additionally, creatinine and BUN levels gradually decreased to baseline values.
Conclusion: To the best of our knowledge, we described a rare case of diclofenac-induced AKI presenting with anuria, a complete cessation of urine flow, in a patient with no previous kidney complications. This case can be explained by the phenomenon known as “quadruple Whammy,” which involves the concurrent use of NSAIDs, ARBs, and diuretics in the setting of hypovolemia.
- Diclofenac
- NSAIDs
- Acute kidney injury
- ARF
How to Cite
References
Ghlichloo I, Gerriets V. Nonsteroidal anti-inflammatory drugs (NSAIDs). Treasure Island: StatPearls; 2022. [Link]
Klomjit N, Ungprasert P. Acute kidney injury associated with non-steroidal anti-inflammatory drugs. European Journal of Internal Medicine. 2022; 101:21-28. [DOI:10.1016/j.ejim.2022.05.003] [PMID]
Dhanvijay P, Misra AK, Varma SK. Diclofenac induced acute renal failure in a decompensated elderly patient. Journal of Pharmacology & Pharmacotherapeutics. 2013; 4(2):155-7. [DOI:10.4103/0976-500X.110916] [PMID] [PMCID]
Alfaro, R. A, Davis D.D. Diclofenac. Treasure Island: StatPearls; 2022. [Link]
Harirforoosh S, Asghar W, Jamali F. Adverse effects of nonsteroidal antiinflammatory drugs: An update of gastrointestinal, cardiovascular and renal complications. Journal of Pharmacy & Pharmaceutical Sciences. 2013; 16(5):821-47. [DOI:10.18433/J3VW2F] [PMID]
Chatterjee S, Dureja GP, Kadhe G, Mane A, Phansalkar AA, Sawant S, et al. Cross-Sectional study for prevalence of non-steroidal anti-inflammatory drug-induced gastrointestinal, cardiac and renal complications in India: Interim report. Gastroenterology Research. 2015; 8(3-4):216-21. [DOI:10.14740/gr658w] [PMID] [PMCID]
eHealthMe. Anuria in diclofenac-How severe and when it was recovered? [Internet]. 2022 [Updated 2024 May 1]. Available from: [Link]
Zhang X, Donnan PT, Bell S, Guthrie B. Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: Systematic review and meta-analysis. BMC Nephrology. 2017; 18(1):256. [DOI:10.1186/s12882-017-0673-8] [PMID] [PMCID]
Ungprasert P, Cheungpasitporn W, Crowson CS, Matteson EL. Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: A systematic review and meta-analysis of observational studies. European Journal of Internal Medicine. 2015; 26(4):285-91. [DOI:10.1016/j.ejim.2015.03.008] [PMID]
Chandana C, Anusha S, Kavya HB. Diclofenac induced rapidly progressive renal failure in elderly patient-A case report. Indian Journal of Pharmacy Practice. 2022; 15(4):315-7. [DOI:10.5530/ijopp.15.4.56]
Tomaszewski M, Zukowska-Szczechowska E, Zywiec J, Grzeszczak W. Transient anuria in a patient with chronic renal failure and liver affection after a single oral dose of diclofenac. Nephron. 2001; 88(3):287-8. [DOI:10.1159/000046009] [PMID]
Shohaib S. Injection of diclofenac precipitating oliguric acute renal failure in a patient with kidney myeloma. Nephron. 2000; 85(1):96. [DOI:10.1159/000045639] [PMID]
Naughton CA. Drug-induced nephrotoxicity. American Family Physician. 2008; 78(6):743-50. [Link]
Hanim Islahudin F, Cheah HM. Beware of triple whammy. Malaysian Journal of Pharmacy 2022; 8(1):38-41. [DOI:10.52494/OPCN8135]
Prieto-García L, Pericacho M, Sancho-Martínez SM, Sánchez Á, Martínez-Salgado C, López-Novoa JM, et al. Mechanisms of triple whammy acute kidney injury. Pharmacology & Therapeutics. 2016; 167:132-45. [DOI:10.1016/j.pharmthera.2016.07.011] [PMID]
Loboz KK, Shenfield GM. Drug combinations and impaired renal function-The 'triple whammy. British Journal of Clinical Pharmacology. 2005; 59(2):239-43. [DOI:10.1111/j.0306-5251.2004.2188.x] [PMID] [PMCID]
Thomas, MC. Diuretics, ACE inhibitors and NSAIDs--the triple whammy. The Medical Journal of Australia. 2000; 172(4):184-5. [DOI:10.5694/j.1326-5377.2000.tb125548.x]
Kunitsu Y, Hira D, Morikochi A, Ueda T, Isono T, Morita SY, et al. Time until onset of acute kidney injury by combination therapy with "triple whammy" drugs obtained from Japanese Adverse Drug Event Report database. Plos One. 2022; 17(2):e0263682. [DOI:10.1371/journal.pone.0263682] [PMID] [PMCID]
Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochemical Pharmacology. 2020; 180:114147. [DOI:10.1016/j.bcp.2020.114147] [PMID] [PMCID]
Lapi F, Azoulay L, Yin H, Nessim SJ, Suissa S. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: Nested case-control study. BMJ. 2013; 346:e8525. [DOI:10.1136/bmj.e8525] [PMID] [PMCID]
- Abstract Viewed: 624 times
- pdf Downloaded: 349 times